OREXIN RECEPTORS (HYPOCRETIN RECEPTOR) ANTAGONIST MARKET ANALYSIS

Orexin Receptors (Hypocretin Receptor) Antagonist Market, by Application (Insomnia, Depression and Anxiety), by Dosage (5mg, 10mg, 15mg, and 20mg), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI2522
Formats :
Excel and PDF
Industry : Pharmaceutical

Orexin Receptors (Hypocretin Receptor) Antagonist MarketSize and Trends

Global Orexin Receptors Antagonist Market Drivers

The main growth driver for the Orexin receptors antagonist market is the rising cases of insomnia. Insomnia is caused by plenty of reasons such as anxiety, stress and depression. Lifestyle problems can trigger insomnia like irregular sleeping patters, drinking alcohol and smoking tobacco products before going to bed. Rising geriatric population, increased stress levels in urban population also results into insomnia. According to American Academy of Sleep Medicine AASM) as reported in 2014 insomnia affects 30% of adults, 15-20% have short term insomnia and 10% of adults have chronic insomnia worldwide.

Growing awareness about insomnia and penetration of Belsomra into the market is expected to create more demand in ORA market. Moreover, studies are being conducted whether suvorexant can be used to treat depression and anxiety so that the ORA market can witness further growth.